A Randomized, Open Label, Multicenter, Phase 4 Study for the Comparison of Efficacy of Tiotropium Plus Salmeterol/ Fluticasone Propionate Compared With Tiotropium Alone in COPD Patients.
Phase of Trial: Phase IV
Latest Information Update: 01 Apr 2010
At a glance
- Drugs Salmeterol/fluticasone propionate; Tiotropium bromide
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 01 Apr 2010 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
- 01 Apr 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 01 Apr 2010 Actual patient number (509) added as reported by ClinicalTrials.gov.